Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA
Sponsor: National Taiwan University Hospital
Summary
This project is a randomized controlled clinical research design, The hypothesis P-I-C-O of the study is: For adult patients in the Taipei City and New Taipei City communities who have suffered sudden non-traumatic death and have been resuscitated by advanced paramedics, the intervention group that receives combined drug treatment (epinephrine, vasopressin, methylprednisolone) has a better rate of sustained recovery of spontaneous circulation (ROSC) (primary outcome) and long-term survival status (secondary outcomes) compared to the control group that receives single drug treatment (epinephrine).
Official title: A Randomized Clinical Trial of Patient Outcomes Following Out-of-Hospital Cardiac Arrest Receiving Epinephrine Versus In-together Vasopressin, Epinephrine, and Steroid. (OHCA REVIVES Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1344
Start Date
2024-07-16
Completion Date
2026-12-31
Last Updated
2025-11-19
Healthy Volunteers
No
Interventions
Combination group
Combination of epinephrine (Adrenaline® 1mg/vial) every 3-5 minutes, vasopressin (Pitressin® 20Unints/vial) every 3-5 minutes up to 4 vials (a total of 80Units), methylprednisolone (Solu-Medrol® 40mg/vial)
Standard group
standard doses of epinephrine (Adrenaline® 1mg/vial) every 3-5 minutes
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan